Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Epidemiology, diagnosis and treatment of asymptomatic tuberculosis: an expert review.
Zaidi, SM A; Miller, C; Falzon, D; Coussens, AK; HOUBEN, RM G J; Esmail, H;
2026
International journal of infectious diseases, (2026).171, 10.1016/j.ijid.2026.109044.
Comment on: Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: A quasi-experimental study.
MCCREESH, N; KHAN, PY;
2026
Therapeutic advances in infectious disease, (2026).13, 10.1177/20499361261477179.
Sex differences in tuberculosis incidence: a pooled analysis of 11 prospective cohort studies.
Hamada, Y; Surenthirarajah, S; Gupta, RK; Quartagno, M; Acuna-Villaorduna, C; Altet, N; Diel, R; Dominguez, J; FLOYD, S; Gupta, A; Jones-López, EC; Lange, C; Van Leth, F; Rueda, IL; Mave, V; Muñoz, L; Paradkar, M; Sester, M; Prasad, H; Shanaube, K; Sharma, SK; Sloot, R; Sotgiu, G; Vashishtha, R; Abubakar, I; ... Rangaka, MX.
2026
eClinicalMedicine, (2026).99, 10.1016/j.eclinm.2026.104146.
Synthesis, Characterization, and Inhibitory Potential of Fagonia arabica L. Phytochemicals Coated Gold Nanoparticles Against Drug-Resistant Mycobacterium tuberculosis.
Mukhtar, F; Khan, MT; Lodhi, MS; Ahmad, I; Alshaya, DS; Al-Qahtani, AA; Khan, AS; CLARK, TG;
2026
Chemistry & biodiversity, (2026).23 8 10.1002/cbdv.71572.
Tuberculosis comorbidities, multimorbidity and mortality amongst adults in South Africa: A prospective cohort study nested in a trial.
Wood, GK; Byrne, RL; Lebina, L; Worrall, E; Abraham, P; WEBB, EL; MacPherson, P; Martinson, NA; Wingfield, T;
2026
PLOS global public health, (2026).6 8 10.1371/journal.pgph.0006720.
Treatment outcomes of individuals with tuberculosis identified from mobile chest X-ray–based active case finding in Pakistan.
Zaidi, SM A; HORTON, KC; Esmail, H;
2026
Public health action, (2026).16 3 10.5588/pha.26.0030.
Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings.
Sunshine, J; Shaffer, M; Han, LL; Gaikwad, D; Houana, AA; Gler, MT; Hadinegoro, SR; Hanekom, WA; Lama, JR; Muyoyeta, M; Musala, S; Nduba, V; Rolla, VC; Roy, T; SUTHERLAND, JS; Khosa, C; WAJJA, A; Walker, TM; Cinar, A; Schmidt, AC; Dagnew, AF; Frahm, N; For TBV02-E01 Study Group,; For TBV02-E01 Study Group,;
2026
Open forum infectious diseases, (2026).13 7 10.1093/ofid/ofag437.
Drivers of sex differences in Mycobacterium tuberculosis immunoreactivity among adolescents and adults in Blantyre, Malawi.
Phiri, MD; Rickman, HM; Mbale, H; Feasey, HR; Nliwasa, M; SCHWALB, A; Mwenyenkulu, TE; Mbendera, KN; Mwandumba, HC; CORBETT, EL; Squire, SB; Henrion, MY; HORTON, KC; MacPherson, P;
2026
BMC global and public health, (2026).4 1 10.1186/s44263-026-00302-w.
New tuberculosis vaccines for people with HIV.
SUMNER, T; CLARK, RA; Prys-Jones, TO; Bakker, R; Churchyard, G; WHITE, RG;
2026
AIDS (London, England) (2026). 10.1097/QAD.0000000000004583.
Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of Mycobacterium avium Complex-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing.
Rukasha, I; Kaapu, KG; Nemaguvhuni, NF; Wells-Hunter, F; Sharma, A; PHELAN, JE; Kolobe, MJ; Lekalakala-Mokaba, MR; Warren, RM; Costa Conceição, E;
2026
Microorganisms, (2026).14 7 10.3390/microorganisms14071596.